Anton Emmanuel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anton Emmanuel has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Christine Norton
Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King’s College London, London, UK
1 shared publication - Doreen McClurg
Glasgow Caledonian University, Glasgow, UK
1 shared publication - Fiona Harris
School of Heath Sciences, University of Stirling, Andrew Millar Building, Stirling FK9 4LF, UK
1 shared publication - Helen Mason
Yunus Centre for Social Business and Health, Glasgow Caledonian University, Glasgow, United Kingdom
1 shared publication - John Norrie
Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK
1 shared publication - Kirsteen Goodman
University of Aberdeen , Health Sciences Building Foresterhill, Aberdeen AB25 2ZD , UK , abdn.ac.uk
1 shared publication
Latest Publications
- Open Access
- 1 September 2021
- Published by Elsevier in Clinical Medicine
- Vol. 21 (5) , e433
In response to crisis, is versatility a reward or a necessity
The pandemic has presented a huge challenge for healthcare providers, nowhere more so than in acute medical units, which are the first point of management for most medical inpatients. The effect of COVID-19 on the function of these units, and how they reorganised their structure, is the subject of a study by Soong et al covering 10 hospitals in five countries and three continents during the first wave of the pandemic.2The success of these reconfigured acute medical services created operational learning that enabled prioritisation of resources during subsequent waves. There are also key papers looking at the service response in oncology, both in an acute setting as well as cancer outpatient care.3,4 Peritoneal dialysis patients are another vulnerable group who have been less studied. Balson and Baharani report on a novel patient-reported questionnaire tool to document patient experience.5 They identified unmet needs in this patient group that have implications for future care.
- 1 September 2021
- Published by Elsevier in Clinical Medicine
- Vol. 21 (5) , e433
Open AccessIn response to crisis, is versatility a reward or a necessity
The pandemic has presented a huge challenge for healthcare providers, nowhere more so than in acute medical units, which are the first point of management for most medical inpatients. The effect of COVID-19 on the function of these units, and how they reorganised their structure, is the subject of a study by Soong et al covering 10 hospitals in five countries and three continents during the first wave of the pandemic.2The success of these reconfigured acute medical services created operational learning that enabled prioritisation of resources during subsequent waves. There are also key papers looking at the service response in oncology, both in an acute setting as well as cancer outpatient care.3,4 Peritoneal dialysis patients are another vulnerable group who have been less studied. Balson and Baharani report on a novel patient-reported questionnaire tool to document patient experience.5 They identified unmet needs in this patient group that have implications for future care.
- 1 October 2018
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 22 (58) , 1-134
Abdominal massage plus advice, compared with advice only, for neurogenic bowel dysfunction in MS: a RCT
Background: Between 50% and 80% of people with multiple sclerosis (PwMS) experience neurogenic bowel dysfunction (NBD) (i.e. constipation and faecal incontinence) that affects quality of life and can lead to hospitalisation. Objectives: To determine the clinical effectiveness and cost-effectiveness of abdominal massage plus advice on bowel symptoms on PwMS compared with advice only. A process evaluation investigated the factors that affected the clinical effectiveness and possible implementation of the different treatments. Design: A randomised controlled trial with process evaluation and health economic components. Outcome analysis was undertaken blind. Setting: The trial took place in 12 UK hospitals. Participants: PwMS who had ‘bothersome’ NBD. Intervention: Following individualised training, abdominal massage was undertaken daily for 6 weeks (intervention group). Advice on good bowel management as per the Multiple Sclerosis Society advice booklet was provided to both groups. All participants received weekly telephone calls from the research nurse. Main outcome measures: The primary outcome was the difference between the intervention and control groups in change in the NBD score from baseline to week 24. Secondary outcomes were measured via a bowel diary, adherence diary, the Constipation Scoring System, patient resource questionnaire and the EuroQol-5 Dimensions, five-level version (EQ-5D-5L). Results: A total of 191 participants were finalised, 189 of whom were randomised (two participants were finalised in error) (control group, n = 99; intervention group, n = 90) and an intention-to-treat analysis was performed. The mean age was 52 years (standard deviation 10.83 years), 81% (n = 154) were female and 11% (n = 21) were wheelchair dependent. Fifteen participants from the intervention group and five from the control group were lost to follow-up. The change in NBD score by week 24 demonstrated no significant difference between groups [mean difference total score –1.64, 95% confidence interval (CI) –3.32 to 0.04; p = 0.0558]; there was a significant difference between groups in the change in the frequency of stool evacuation per week (mean difference 0.62, 95% CI 0.03 to 1.21; p = 0.039) and in the number of times per week that participants felt that they emptied their bowels completely (mean difference 1.08, 95% CI 0.41 to 1.76; p = 0.002), in favour of the intervention group. Of participant interviewees, 75% reported benefits, for example less difficulty passing stool, more complete evacuations, less bloated, improved appetite, and 85% continued with the massage. A cost–utility analysis conducted from a NHS and patient cost perspective found in the imputed sample with bootstrapping a mean incremental outcome effect of the intervention relative to usual care of –0.002 quality-adjusted life-years (QALYs) (95% CI –0.029 to 0.027 QALYs). In the same imputed sample with bootstrapping, the mean incremental cost effect of the intervention relative to usual care was £56.50 (95% CI –£372.62 to £415.68). No adverse events were reported. Limitations include unequal randomisation, dropout and the possibility of ineffective massage technique. Conclusion: The increment in the primary outcome favoured the intervention group, but it was small and not statistically significant. The economic analysis identified that the intervention was dominated by the control group. Given the small improvement in the primary outcome, but not in terms of QALYs, a low-cost version of the intervention might be considered worthwhile by some patients. Future work: Research is required to establish possible mechanisms of action and modes of massage delivery. Trial registration: Current Controlled Trials ISRCTN85007023 and NCT03166007. Funding: This project was funded by the National Institute for Health Research Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 22, No. 58. See the NIHR Journals Library website for further project information.
- 1 October 2018
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 22 (58) , 1-134
Abdominal massage plus advice, compared with advice only, for neurogenic bowel dysfunction in MS: a RCT
Background: Between 50% and 80% of people with multiple sclerosis (PwMS) experience neurogenic bowel dysfunction (NBD) (i.e. constipation and faecal incontinence) that affects quality of life and can lead to hospitalisation. Objectives: To determine the clinical effectiveness and cost-effectiveness of abdominal massage plus advice on bowel symptoms on PwMS compared with advice only. A process evaluation investigated the factors that affected the clinical effectiveness and possible implementation of the different treatments. Design: A randomised controlled trial with process evaluation and health economic components. Outcome analysis was undertaken blind. Setting: The trial took place in 12 UK hospitals. Participants: PwMS who had ‘bothersome’ NBD. Intervention: Following individualised training, abdominal massage was undertaken daily for 6 weeks (intervention group). Advice on good bowel management as per the Multiple Sclerosis Society advice booklet was provided to both groups. All participants received weekly telephone calls from the research nurse. Main outcome measures: The primary outcome was the difference between the intervention and control groups in change in the NBD score from baseline to week 24. Secondary outcomes were measured via a bowel diary, adherence diary, the Constipation Scoring System, patient resource questionnaire and the EuroQol-5 Dimensions, five-level version (EQ-5D-5L). Results: A total of 191 participants were finalised, 189 of whom were randomised (two participants were finalised in error) (control group, n = 99; intervention group, n = 90) and an intention-to-treat analysis was performed. The mean age was 52 years (standard deviation 10.83 years), 81% (n = 154) were female and 11% (n = 21) were wheelchair dependent. Fifteen participants from the intervention group and five from the control group were lost to follow-up. The change in NBD score by week 24 demonstrated no significant difference between groups [mean difference total score –1.64, 95% confidence interval (CI) –3.32 to 0.04; p = 0.0558]; there was a significant difference between groups in the change in the frequency of stool evacuation per week (mean difference 0.62, 95% CI 0.03 to 1.21; p = 0.039) and in the number of times per week that participants felt that they emptied their bowels completely (mean difference 1.08, 95% CI 0.41 to 1.76; p = 0.002), in favour of the intervention group. Of participant interviewees, 75% reported benefits, for example less difficulty passing stool, more complete evacuations, less bloated, improved appetite, and 85% continued with the massage. A cost–utility analysis conducted from a NHS and patient cost perspective found in the imputed sample with bootstrapping a mean incremental outcome effect of the intervention relative to usual care of –0.002 quality-adjusted life-years (QALYs) (95% CI –0.029 to 0.027 QALYs). In the same imputed sample with bootstrapping, the mean incremental cost effect of the intervention relative to usual care was £56.50 (95% CI –£372.62 to £415.68). No adverse events were reported. Limitations include unequal randomisation, dropout and the possibility of ineffective massage technique. Conclusion: The increment in the primary outcome favoured the intervention group, but it was small and not statistically significant. The economic analysis identified that the intervention was dominated by the control group. Given the small improvement in the primary outcome, but not in terms of QALYs, a low-cost version of the intervention might be considered worthwhile by some patients. Future work: Research is required to establish possible mechanisms of action and modes of massage delivery. Trial registration: Current Controlled Trials ISRCTN85007023 and NCT03166007. Funding: This project was funded by the National Institute for Health Research Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 22, No. 58. See the NIHR Journals Library website for further project information.